Cell and Gene Therapy: Exploring the Complex Manufacturing Landscape

The field of cell and gene therapy (CGT) is rapidly evolving, with cutting-edge advancements in manufacturing technologies, regulatory frameworks, and logistical strategies. These therapies, which involve the manipulation of cells or genes to treat diseases, offer transformative potential for patients, especially those with rare or chronic conditions. However, the manufacturing processes for CGTs present numerous challenges and complexities, as they require innovative solutions to scale production and reduce costs. In this overview, we will explore the key drivers, challenges, and regulatory landscape of CGT manufacturing, along with the technological solutions emerging to address these issues